Home » NeoGenomics Announces Entry Into Flow Cytometry Testing Market
NeoGenomics Announces Entry Into Flow Cytometry Testing Market
NeoGenomics has received all regulatory approvals to offer flow cytometry testing services and has formally entered this market. Flow cytometry uses sophisticated laser-based equipment to analyze cell surface markers and is very effective at diagnosing certain types of cancer.
Business Wire (http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20050209005148&newsLang=en)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May